Tag Archives: GI & liver

EUH Morning Report: In patients with acute alcoholic hepatitis, does steroid therapy increase the risk of GI bleeding compared to no use of steroids?

The Bottom Line: For patients with acute alcoholic hepatitis, there isn’t literature to answer the question of whether steroid therapy increases risk of GI bleeding compared to no use of steroids. For patients with non-acute alcoholic liver disease who do not have concomitant … Continue reading

Posted in Applying evidence, EUH, Therapy | Tagged

VA Resident Report: What is the effectiveness of POEM for achalasia?

Available data suggests POEM is very effective in the relief of symptoms in patients with achalasia. However, POEM is associated with a very high incidence of pathologic reflux. The clinical sequalae of the increase in pathologic reflux are currently incompletely … Continue reading

Posted in VA | Tagged

VA Resident Report: What are the adverse effects of PPI use on B12 levels?

The Bottom Line: Studies of PPI use and vitamin B12 deficiency have yielded mixed results. Absorption decreased from 3.2 to 0.9% (P ¼ 0.031) in patients on omeprazole 20 mg daily, and from 3.4 to 0.4% in patients on higher … Continue reading

Posted in VA | Tagged

VA Resident Report: What are the gastrointestinal manifestations of cryptosporidium ?

The cardinal symptom is diarrhea, which is typically watery, and accompanied by abdominal cramps, fatigue, nausea, and anorexia. Fever and vomiting may occur. Diarrhea tends to persist longer (median of 5 to 10 days) than that seen with other etiologies … Continue reading

Posted in VA | Tagged

VA Resident Report: At what value does hypertriglyceridemia cause acute pancreatitis?

Acute pancreatitis is a relatively common medical condition with variable aetiologies and a mortality up-to 20%. Gallstones and excess alcohol consumption are the leading aetiologies in the developed world; whilst metabolic, congenital and iatrogenic causes are responsible for 20–25% of … Continue reading

Posted in VA | Tagged

Intermittent vs Continuous Proton Pump Inhibitor Therapy for High-Risk Bleeding Ulcers A Systematic Review and Meta-analysis

Sachar, Hamita, KetaVaidya, and LorenLaine. “Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis.” JAMA internal medicine 174.11 (2014):1755-62. Conclusion: “Intermittent PPI therapy is comparable to the current guideline-recommended regimen of intravenous bolus … Continue reading

Posted in Applying evidence, EUH, Therapy | Tagged

Checking Hepatitis B surface antigen levels after treatment

HBsAg levels at 6 months of LMV-ADV combination therapy can help predict treatment response. More potent treatments should be considered for cases positive for HBeAg, with high baseline HBV DNA and high HBsAg levels after 6 months treatment. Kim, Jeong … Continue reading

Posted in EUHMidtown | Tagged